Riverside Shore Cancer Center — Onancock, Virginia

Riverside Shore Cancer Center is a clinical research site located in Onancock, Virginia, United States 23417.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Riverside Shore Cancer Center has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Riverside Shore Cancer Center?

Riverside Shore Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Riverside Shore Cancer Center conducted?

Riverside Shore Cancer Center has 4 clinical trials on record, with 4 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma.

Is Riverside Shore Cancer Center accredited by Crixeo Health?

Yes — Riverside Shore Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Riverside Shore Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.